TURKOVAC Statement from a Member of the Scientific Committee

One of the issues that Turkey has been talking about, especially in recent days, TURKOVAC domestic coronavirus vaccine. Developed as a result of a long-term study, the vaccine has been emergency use approval took. According to the statements made by Minister of Health Fahrettin Koca, native COVID-19 vaccineIt is in mass production and will be used in the coming days.

Associate Professor Doctor, Member of the Coronavirus Scientific Committee of the Ministry of Health, who made statements about the vaccine developed within the body of Kayseri Erciyes University. Afsin Emre Kaymazmaz He talked about the effectiveness of the vaccine. Making very promising sentences, Kaymazmaz said that TURKOVAC’s inactive coronavirus vaccine named CoronaVac developed by Sinovac is more effective stated. Kaymazmaz did not share any figures on the subject.

90.7 percent effective

“Currently, the data we have shows that TURKOVAC vaccine is very effective in terms of safety and efficacy, even other inactivated vaccines administered in our country. It is more effective than Sinovac. has revealed. In particular, our expectation from vaccines is to prevent serious illness and death. In this respect, it is also associated with severe illness and death in the TURKOVAC group. not encountered A very welcome development.“Kaymazmaz also made evaluations about whether the vaccine can be used in the young population. That evaluation was as follows: The currently applicable emergency use approval was obtained as a result of clinical studies involving individuals aged 18 years and older. But about this, between the ages of 12-18 or Including 5-11 years old We can answer this question when studies are done and data about it are obtained.

Another point that Afşin Emre Kaymazmaz mentioned is that TURKOVAC’s in the international community status. Making very important statements at this point, the Scientific Committee Member said that TURKOVAC is WHO approved, which means that the validity of the vaccine covers the whole world. “This work world Health OrganizationIt was one of his works. If the destination country accepts the inactivated vaccine and our TURKOVAC vaccine when going abroad when it is approved for emergency use by WHO. there will be no problem in this sense. This is one of the topics that will be on the agenda in the coming days.‘ said Kaymazmaz, explaining what awaits Turkey.